Catalyst Event
Gilead Sciences Inc (GILD) · Other
From Akros SCHK HK-U.S. Tech 100 Index (ASHUSTC)
4/29/2026, 12:00:00 AM
The U.S. FDA accepted for Priority Review the New Drug Application (NDA) for the investigational once-daily single-tablet HIV treatment regimen, bictegravir/lenacapavir (BIC/LEN) on 2026-04-29. This major regulatory milestone is estimated to have a high price impact of over 10% due to the significance of the HIV franchise.
Korean Translation
2026년 4월 29일 미국 FDA가 1일 1회 단일정 HIV 치료제 후보물질 빅테그라비르/레나카파비르(BIC/LEN)의 신약허가신청(NDA)을 우선심사 대상으로 접수함. HIV 사업부의 중요성을 고려할 때 10% 이상의 높은 주가 영향이 예상됨.
Related Recent Events
WuXi Biologics (Cayman) Inc (2269) · Other
The U.S. Office of Management and Budget (OMB) is scheduled to publish a full list of 'biotechnology companies of concern' (BCCs) by December 18, 2026, under the BIOSECURE Act; High importance is justified by the potential for severe regulatory risk causing a >10% price impact scheduled.
12/18/2026, 12:00:00 AM
Honeywell International Inc (HON) · Trading Issue
Honeywell Aerospace spin-off is scheduled to be completed on June 29, 2026, marking the final step in the company's portfolio transformation. The new company will trade under the ticker 'HONA'. This event is scheduled.
6/29/2026, 12:00:00 AM
BYD Electronic International Co Ltd (285) · Other
Ex-dividend date (2026-06-11) for the final dividend of RMB 0.156 per share for the year ended December 31, 2025, scheduled. Low importance as dividend distributions typically result in price adjustments of ~1%.
6/11/2026, 12:00:00 AM
Honeywell International Inc (HON) · Other
A quarterly dividend of $1.19 per share is scheduled to be paid on June 5, 2026, to shareholders of record as of May 17, 2026. This event is scheduled.
6/5/2026, 12:00:00 AM
Time Interconnect Technology Ltd (1729) · Other
Annual General Meeting on 2026-05-29 to approve FY2025 results, a final dividend of HK2.4 cents per share, and a mandate to issue up to 20% new shares scheduled.
5/29/2026, 12:00:00 AM
SALESFORCE INC (CRM) · Earnings Release
Salesforce is scheduled to release its Q1 FY2027 earnings results on May 27, 2026, after market close. Importance is estimated as Low based on historical price stability during similar announcements, scheduled.
5/27/2026, 12:00:00 AM